Pulmonary complications of sickle cell disease

Affiliations

¹ Division of Pulmonary, Allergy, and Critical Care Medicine and the Hemostasis and Vascular Biology Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA. gladwinmt@upmc.edu

Review

Mark T Gladwin et al. N Engl J Med. 2008.

. 2008 Nov 20;359(21):2254-65.

doi: 10.1056/NEJMra0804411.

¹ Division of Pulmonary, Allergy, and Critical Care Medicine and the Hemostasis and Vascular Biology Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA. gladwinmt@upmc.edu

No abstract available

Comment in

Pulmonary complications of sickle cell disease.
Firth PG. Firth PG. N Engl J Med. 2009 Mar 5;360(10):1044; author reply 1044-5. doi: 10.1056/NEJMc082638. N Engl J Med. 2009. PMID: 19264697 No abstract available.
Rationale for IL-1beta targeted therapy for ischemia-reperfusion induced pulmonary and other complications in sickle cell disease.
Wanderer AA. Wanderer AA. J Pediatr Hematol Oncol. 2009 Aug;31(8):537-8. doi: 10.1097/MPH.0b013e3181acd89d. J Pediatr Hematol Oncol. 2009. PMID: 19636265 No abstract available.